Jawed had joined the role in June 2018 after quitting Novartis within 15 days of being appointed to lead the Swiss drug company’s India business. Andrew Lane, Abbott’s Executive Vice President, Established pharmaceuticals said in a statement that Jawed is leaving Abbott for personal reasons.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39KlQjk
via IFTTT
0 comments:
Post a Comment